Delivery Order SPE2DB24D1021-SPE2DB25FEZLT
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,273.37 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count units) on September 9, 2025, with completion scheduled for September 10, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation reflects a routine pharmaceutical procurement fulfilling military healthcare supply requirements. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Januvia 100 mg tablets (90-count packages) valued at $1,718.04. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 10, 2025, to be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single line item purchase under AmerisourceBergen's existing pharmaceutical supply relationship...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Januvia 50 mg tablets (90-count package) valued at $1,109.94 under a firm fixed-price contract. This delivery order, issued on August 22, 2025, represents a non-competitive, non-set-aside award with an ultimate completion date of August 25, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary operations....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Januvia 100 mg tablets (90-count) under a firm fixed-price contract valued at $1,122.20. The award, which is effective through August 19, 2025, was issued as a non-set-aside competitive award and represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $2,182.92 to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg on July 30, 2025, with a completion date of July 31, 2025. This competitively awarded, firm fixed-price delivery order represents a pharmaceutical supply transaction supporting federal medical procurement needs. The contract carries no set-aside designation and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $5,440.00 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count) on August 6, 2025, with a completion date of August 7, 2025. This non-set-aside, competitively awarded contract utilized firm fixed pricing and represents a routine pharmaceutical procurement through AmerisourceBergen's existing contract vehicle. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $2,182.92 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Januvia 100 mg tablets (90-count units). This firm fixed-price delivery order, with an ultimate completion date of July 15, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- The Defense Logistics Agency awarded a $15,034.57 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Januvia 100 mg tablets (90-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 30, 2025, and represents a child order under AmerisourceBergen's broader pharmaceutical supply agreements. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,101.75 for Januvia 50 mg tablets (90-count) on August 11, 2025, with an ultimate completion date of August 12, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and is performed at the awardee's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with the federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $7,891.24 on August 6, 2025, for the supply of Januvia 50 mg tablets (90-count packages). This is a firm fixed-price delivery order with an ultimate completion date of August 7, 2025, to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The award utilized no set-aside designation and was competitively awarded through open competition. This delivery order is issued under...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FEZLTDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,779.46 to AmerisourceBergen Drug Corp for Januvia 100 mg tablets (90-count supply) on August 8, 2025, with an ultimate completion date of August 11, 2025. This is a firm fixed price, non-set-aside contract for delivery to the vendor's corporate headquarters location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader federal pharmaceutical supply relationship with the federal government. This award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare systems worldwide. Through this contract vehicle, AmerisourceBergen provides critical pharmaceutical products to customers including the Defense Health Agency and U.S. Coast Guard. The company's consistent receipt of competitively awarded delivery orders demonstrates its capability to meet federal medical procurement requirements at varied transaction values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 8/8/25 |